162 related articles for article (PubMed ID: 17668170)
1. [The molecular pathogenesis and prognosis of renal cell carcinoma].
Serth J
Urologe A; 2007 Sep; 46(9):1168-9. PubMed ID: 17668170
[No Abstract] [Full Text] [Related]
2. [Pathogenesis of pancreatic carcinoma].
Schmid RM
Z Gastroenterol; 2002 Dec; 40 Suppl 2():58-61. PubMed ID: 12467012
[No Abstract] [Full Text] [Related]
3. [Expression of p16 and p16 beta in squamous epithelial carcinomas and adenocarcinomas of the esophagus: differences in regulation dependent on kind of tumor and histology].
Metzger R; Danenberg K; Hayashi K; Hölscher AH; Danenberg PV
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):491-4. PubMed ID: 14518304
[TBL] [Abstract][Full Text] [Related]
4. Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappaB is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure.
Konda R; Sugimura J; Sohma F; Katagiri T; Nakamura Y; Fujioka T
J Urol; 2008 Aug; 180(2):481-5. PubMed ID: 18550099
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathology of renal cell carcinoma.
Störkel S
Urologe A; 2004 Sep; 43 Suppl 3():S118-9. PubMed ID: 15164177
[No Abstract] [Full Text] [Related]
6. [Introduction to the topic: molecular biological elucidation of renal cell carcinoma].
Küfer R; Hautmann R
Urologe A; 2006 Mar; 45(3):295-6. PubMed ID: 16482464
[No Abstract] [Full Text] [Related]
7. [Cyto- and molecular genetic studies of renal cell carcinoma with special reference to multifocal carcinoma lesions].
Schlichter A; Junker K; Kosmehl H; Katenkamp D; Claussen U; Schubert J
Urologe A; 1996 Jul; 35(4):305-9. PubMed ID: 8928359
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
[TBL] [Abstract][Full Text] [Related]
9. [Transcriptome expression analyses of pulmonary renal cell carcinoma metastases].
Wuttig D; Höfling C; Füssel S; Meinhardt M; Herr A; Tennstedt P; Holotiuk O; Baretton G; Meye A; Grimm MO; Rolle A; Wirth MP
Urologe A; 2007 Sep; 46(9):1291-2. PubMed ID: 17619850
[No Abstract] [Full Text] [Related]
10. [Molecular genetic aspects of solid tumors. Presentation of modern study approaches exemplified by renal cell cancer].
Strohmeyer T; Ackermann R
Med Klin (Munich); 1993 Jan; 88(1):28-34. PubMed ID: 8094882
[No Abstract] [Full Text] [Related]
11. [Aberrant methylation of tumor suppressor genes in renal cell carcinoma].
Zhang Q; Jin J; Tao Q
Ai Zheng; 2007 Nov; 26(11):1276-80. PubMed ID: 17991333
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of DNA index in renal-cell carcinoma.
Devonec M; Bringuier PP; Hijazi A; Dutrieux-Berger N; Revillard JP; Perrin P
Prog Clin Biol Res; 1990; 348():35-48. PubMed ID: 2385607
[No Abstract] [Full Text] [Related]
14. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of cyclin D1, D3, and p21 in an infantile renal carcinoma with Xp11.2 TFE3-gene fusion.
Müller-Höcker J; Babaryka G; Schmid I; Jung A
Pathol Res Pract; 2008; 204(8):589-97. PubMed ID: 18358634
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of p16 by CpG hypermethylation in renal cell carcinoma.
Vidaurreta M; Maestro ML; Sanz-Casla MT; Maestro C; Rafael S; Veganzones S; Moreno J; Blanco J; Silmi A; Arroyo M
Urol Oncol; 2008; 26(3):239-45. PubMed ID: 18452812
[TBL] [Abstract][Full Text] [Related]
19. Early and late genetic changes in clear cell renal carcinoma.
Moch H
Urologe A; 2004 Sep; 43 Suppl 3():S121. PubMed ID: 15164178
[No Abstract] [Full Text] [Related]
20. Genome-wide DNA methylation profiles in renal tumors of various histological subtypes and non-tumorous renal tissues.
Arai E; Wakai-Ushijima S; Fujimoto H; Hosoda F; Shibata T; Kondo T; Yokoi S; Imoto I; Inazawa J; Hirohashi S; Kanai Y
Pathobiology; 2011; 78(1):1-9. PubMed ID: 21474971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
